REGULUS THERAPEUTICS INC - COM (RGLS)

CUSIP: 75915K101

Q4 2015 13F Holders as of 31 Dec 2015

Type / Class
Equity / COM
Total 13F shares
34,262,000
Share change
-1,001,964
Total reported value
$298,845,791
Put/Call ratio
23%
Price per share
$8.72
Number of holders
104
Value change
-$7,416,860
Number of buys
52
Number of sells
37

Quarterly Holders Quick Answers

What is CUSIP 75915K101?
CUSIP 75915K101 identifies RGLS - REGULUS THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of REGULUS THERAPEUTICS INC - COM (RGLS) as of Q4 2015

As of 31 Dec 2015, REGULUS THERAPEUTICS INC - COM (RGLS) was held by 104 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 34,262,000 shares. The largest 10 holders included FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, RA CAPITAL MANAGEMENT, LLC, UBS ASSET MANAGEMENT AMERICAS INC, Capital World Investors, Foresite Capital Management II, LLC, BlackRock Fund Advisors, VANGUARD GROUP INC, AXA, and GOLDMAN SACHS GROUP INC. This page lists 104 institutional shareholders reporting positions in this security for the Q4 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.